Compounds > dihydroergotamine
Page last updated: 2024-08-21

dihydroergotamine and Coronary Disease

dihydroergotamine has been researched along with Coronary Disease in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19906 (75.00)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Riecker, G1
Schwalb, H1
Branca, E; Meniconi, L; Tini Brunozzi, L1
Creutzig, A1
Kreuzer, H; Menzel, F; Schmidt, G; Vetterlein, F1
Gratzl, O; Rem, JA; Reymond, MA1
Husfeldt, KJ; Kaiser, H; Majer, M; Schäfer, D; Sunder-Plassmann, L; Voigt, J; Welzel, D; Wolf, H1
Ockelford, P1

Trials

1 trial(s) available for dihydroergotamine and Coronary Disease

ArticleYear
Heparin 1986. Indications and effective use.
    Drugs, 1986, Volume: 31, Issue:1

    Topics: Clinical Trials as Topic; Coronary Disease; Dihydroergotamine; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Heparin; Humans; Infusions, Parenteral; Intracranial Embolism and Thrombosis; Partial Thromboplastin Time; Pregnancy; Thromboembolism; Thrombophlebitis; Thrombosis

1986

Other Studies

7 other study(ies) available for dihydroergotamine and Coronary Disease

ArticleYear
[Cardiology 1983--results, problems, developments].
    Der Internist, 1983, Volume: 24, Issue:7

    Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon; Arrhythmias, Cardiac; Bundle of His; Captopril; Cardiac Glycosides; Coronary Disease; Coronary Vessels; Dihydroergotamine; Echocardiography; Electrocoagulation; Fibrinolysis; Heart Failure; Heparin; Humans; Myocardial Infarction; Pacemaker, Artificial; Thromboembolism

1983
[Letter: Coronary spasm following ergotamine medication].
    MMW, Munchener medizinische Wochenschrift, 1975, Sep-05, Volume: 117, Issue:36

    Topics: Adult; Angina Pectoris; Coronary Disease; Coronary Vessels; Dihydroergotamine; Ergotamine; Headache; Humans; Male; Migraine Disorders

1975
[The dihydroergotamine test in the differential diagnosis of repolarization anomalies].
    Minerva cardioangiologica, 1975, Volume: 23, Issue:8

    Topics: Coronary Disease; Diagnosis, Differential; Dihydroergotamine; Ergotamines; Heart Conduction System; Humans; Neurocirculatory Asthenia

1975
[Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
    Deutsche medizinische Wochenschrift (1946), 1992, Nov-06, Volume: 117, Issue:45

    Topics: Coronary Disease; Dihydroergotamine; Ergotamine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Mitral Valve Insufficiency

1992
Acute changes in microvascular blood flow distribution in the myocardium of the rat during partial occlusion of the right coronary artery; effects of dihydroergotamine.
    International journal of microcirculation, clinical and experimental, 1991, Volume: 10, Issue:4

    Topics: Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Dihydroergotamine; Male; Microcirculation; Perfusion; Rats; Rats, Inbred Strains; Time Factors

1991
[Complications of thromboembolic prophylaxis with heparin-dihydroergotamine].
    Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression, 1989, Volume: 30, Issue:6

    Topics: Adult; Aged; Coronary Disease; Dihydroergotamine; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Humans; Intervertebral Disc Displacement; Male; Prospective Studies

1989
[Evaluation of the prevention of perioperative thromboembolism with low molecular weight heparin and dihydroergotamine. A study of the incidence of lethal pulmonary embolisms and undesired symptoms, especially the risk of vasospasm and myocardial infarcti
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:10

    Topics: Coronary Disease; Coronary Vasospasm; Dihydroergotamine; Female; Heparin; Humans; Male; Myocardial Infarction; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Risk Factors

1988